UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|11/20/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and moreStat News|11/20/2026
UNVERIFIEDSingle SourceSTAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in ChinaStat News|11/20/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about a Merck AI deal, China and the pharma supply chain, and moreStat News|11/19/2026
UNVERIFIEDSingle SourceSTAT+: NIH to move last group of its research chimps to a sanctuaryStat News|11/18/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about Overton FDA nomination being yanked, a Merck setback, and moreStat News|11/18/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and moreStat News|11/17/2026
UNVERIFIEDSingle SourceSTAT+: Expert warns of battleground over global access to newer GLP-1 drugs for obesityStat News|11/16/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about GLP-1 use, Covid-19 vaccine investment returns, and moreStat News|11/16/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and moreStat News|9/17/2026